SymBio Pharmaceuticals Ltd Sustainability Reports
SymBio Pharmaceuticals Limited is a commercial-stage biopharmaceutical venture company specializing in the research, development, and commercialization of therapies for oncology, hematology, and infectious diseases. The company principalmente addresses underserved medical needs such as orphan drugs and niche therapeutic fields.
Sector: Manufacturing
Country: Japan
Exchange: Tokyo Stock Exchange
FIGI: BBG001TB4SF9
17 reports from 2011 to 2025